Other Global Peers |
ALIGN TECHNOLOGY INC (NASDAQ), IDEXX LABORATORIES INC (NASDAQ), BAXTER INTERNATIONAL INC (NYSE), DEXCOM INC (NASDAQ), AGILENT TECHNOLOGIES INC (NYSE), ALCON AG (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), RESMED INC (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), WEST PHARMACEUTICAL SERVICES INC (NYSE), COOPER COS INC (NYSE), TELEFLEX INC (NYSE), HOLOGIC INC (NASDAQ), BIO RAD LABORATORIES INC (NYSE), INSULET CORPORATION (NASDAQ), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), WATERS CORP (NYSE), VARIAN MEDICAL SYSTEMS INC (NYSE), NOVOCURE LTD (NASDAQ), STERIS PLC (NYSE), ABIOMED INC (NASDAQ), PERKINELMER INC (NYSE), MASIMO CORPORATION (NASDAQ), FISHER & PAYKEL HEALTHCARE CORP (ASX), DENTSPLY SIRONA INC (NASDAQ), QIAGEN NV (NYSE), COCHLEAR LTD (ASX), MICROPORT (HKEx), TOPGLOV (Bursa), PENUMBRA INC (NYSE), BRUKER CORPORATION (NASDAQ), HARTA (Bursa), WEIGAO GROUP (HKEx), SOTERA HEALTH CO (NASDAQ), HILL-ROM HOLDINGS INC (NYSE), QUIDEL CORP (NASDAQ), HAEMONETICS CORP (NYSE), INSPIRE MEDICAL SYSTEMS INC (NYSE), GLOBUS MED INC (NYSE), ENVISTA HOLDINGS CORPORATION (NYSE), TANDEM DIABETES CARE INC (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), NEVRO CORP (NYSE), CARDIOFLOW-B (HKEx), INARI MEDICAL INC (NASDAQ), STAAR SURGICAL CO (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), ICU MEDICAL INC (NASDAQ), NEOGEN CORP (NASDAQ), GLAUKOS CORPORATION (NYSE), CAREDX INC (NASDAQ), ORTHO CLINICAL DIAGNOSTCS HLDGS PLC (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), VENUS MEDTECH-B (HKEx), LIVANOVA PLC (NASDAQ), BUTTERFLY NETWORK INC (NYSE), CONMED CORP (NYSE), EBOS GROUP (ASX), CANTEL MEDICAL CORP (NYSE), NUVASIVE INC (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), SUPERMX (Bursa), ATRICURE INC (NASDAQ), INMODE LTD (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), EARGO INC (NASDAQ), VERICEL CORP (NASDAQ), AVANOS MEDICAL INC (NYSE), LIFETECH SCI (HKEx), OUTSET MEDICAL INC (NASDAQ), NANO-X IMAGING LTD (NASDAQ), PEIJIA-B (HKEx), PULMONX CORPORATION (NASDAQ), AXONICS MODULATION TECHNLOGS INC (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), HESKA CORP (NASDAQ), KANGJI MEDICAL (HKEx), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), AK MEDICAL (HKEx), ESTABLISHMENT LABS HLDGS INC (NASDAQ), DERMTECH INC (NASDAQ), GENMARK DIAGNOSTICS INC (NASDAQ), NANOSONICS LIMITED (ASX), MESA LABORATORIES INC (NASDAQ), 908 DEVICES INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), INOGEN INC (NASDAQ), ATRION CORP (NASDAQ), CIRC (HKEx), CELLDEX THERAPEUTICS INC (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), CERUS CORP (NASDAQ), SI BONE INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), CRYOLIFE INC (NYSE), TRANSMEDICS GROUP INC (NASDAQ), BASECARE-B (HKEx), ORTHOFIX MEDICAL INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), AXOGEN INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), CHUNLI MEDICAL (HKEx), KDL MEDICAL (HKEx), ANGIODYNAMICS INC (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), PULSE BIOSCIENCES INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), LUCIRA HEALTH INC (NASDAQ), SURMODICS INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), VIEWRAY INC (NASDAQ), BIOVENTUS INC (NASDAQ), VAPOTHERM INC (NYSE), CUTERA INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), ACUTUS MEDICAL INC (NASDAQ), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), STEREOTAXIS INC (NYSE American), ZYNEX INC (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), CORMEDIX INC (NASDAQ), AVITA THERAPEUTICS INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), ACCURAY INCORPORATED (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), QUOTIENT LTD (NASDAQ), PROFOUND MED CORP (NASDAQ), TALIS BIOMEDICAL CORP (NASDAQ), MCP INCOME OPPORTUNITIES TRUST (ASX), MEDAVAIL HOLDINGS INC (NASDAQ), SIENTRA INC (NASDAQ), CYTOSORBENTS CORP (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), NEURONETICS INC (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), YESTAR HEALTH (HKEx), CLEANSPACE HOLDINGS LTD (ASX), PAVMED INC (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), INVACARE CORP (NYSE), MEDICAL DEVELOPMENT INTL (ASX), UTAH MEDICAL PRODUCTS (NASDAQ), MISONIX INC (NASDAQ), SOLITON INC (NASDAQ), AROA BIOSURGERY LTD (ASX), IRADIMED CORP (NASDAQ), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), DARIOHEALTH CORP (NASDAQ), SURGALIGN HOLDINGS INC (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), TELA BIO INC (NASDAQ), TITAN MEDICAL INC (NASDAQ), ALPHA PRO TECH (NYSE American), INTRICOM CORP (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), CYCLOPHARM LIMITED (ASX), MODERN DENTAL (HKEx), CONFORMIS INC (NASDAQ), INCANNEX HEALTHCARE LTD (ASX), REPRO MEDSYSTEMS INC (NASDAQ), ONCOCYTE CORP (NYSE American), AVINGER INC (NASDAQ), KELFRED (HKEx), VINCENT MED (HKEx), NEMAURA MEDICAL INC (NASDAQ), IMAGION BIOSYSTEMS LIMITED (ASX), VENUS CONCEPT INC (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), FONAR CORP (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), MICRO-X LTD (ASX), BIOLASE INC (NASDAQ), EMVISION MEDICAL DEVICES LTD (ASX), PW MEDTECH (HKEx), ZOSANO PHARMA CORP (NASDAQ), CELSION CORPORATION (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), ROCKWELL MEDICAL INC (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), IMPEDIMED LIMITED (ASX), SOMNOMED LIMITED (ASX), OPTISCAN IMAGING (ASX), CHEMBIO DIAGNOSTICS INC (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), VOLITIONRX LIMITED (NYSE American), LIANLUO SMART LIMITED (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), ATOMO DIAGNOSTICS LIMITED (ASX), ELECTROCORE INC (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), LENSAR INC (NASDAQ), NEOVASC INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), ELECTROMED INC (NYSE American), APPLIED UV INC (NASDAQ), IRIDEX CORP (NASDAQ), XTANT MEDICAL HLDGS INC (NYSE American), NEPHROS INC (NASDAQ), IMMUCELL CORP (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), YUNNAN ENERGY (HKEx), RGTBHD (Bursa), SDI LTD (ASX), BIOMERICA INC (NASDAQ), LKL (Bursa), RESPIRI LTD (ASX), RESONANCE HEALTH LTD (ASX), CANCER GENETICS INC (NASDAQ), CHECK-CAP LTD (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), CARDIEX LTD (ASX), BELLEROPHON THERAPEUTICS INC (NASDAQ), COMPUMEDICS (ASX), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), HANCOCK JAFFE LABORATORIES INC (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), DAXOR CORP (NYSE American), MOTUS GI HOLDINGS INC (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), NOVA EYE MEDICAL LIMITED (ASX), DIMERIX LTD (ASX), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), RESAPP HEALTH LIMITED (ASX), TENAX THERAPEUTICS INC (NASDAQ), NEUROTECH INTERNATIONAL LTD (ASX), ALLEGRA ORTHOPAEDICS LIMITED (ASX), AKERS BIOSCIENCES INC (NASDAQ), AETHLON MEDICAL INC (NASDAQ), OBALON THERAPEUTICS INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), OVENTUS MEDICAL LTD (ASX), LIFE HEALTHCARE (HKEx), CYANOTECH CORP (NASDAQ), TRUSCREEN GROUP LTD (ASX), DYNATRONICS CORP (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), LBT INNOVATIONS LTD (ASX), CHF SOLUTIONS INC (NASDAQ), RA MEDICAL SYSTEMS INC (NYSE American), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), USCOM LTD (ASX), METALICITY LIMITED (ASX), STAR EQUITY HOLDINGS INC (NASDAQ), NEUROMETRIX INC (NASDAQ), ADHERIUM LIMITED (ASX), DORSAVI LTD (ASX), ANALYTICA (ASX), INSPIREMD INC (NYSE American), HUAKANG BIOMED (HKEx), MEDIGARD LIMITED (ASX), STHAI (SET) |